Scancell (LON:SCLP) Stock Crosses Below 200-Day Moving Average – What’s Next?

Scancell Holdings plc (LON:SCLP)’s share price passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 12.61 ($0.16) and traded as low as GBX 8.34 ($0.11). Scancell shares last traded at GBX 8.40 ($0.11), with a volume of 32,604 shares traded.

Scancell Price Performance

The company has a quick ratio of 13.01, a current ratio of 3.42 and a debt-to-equity ratio of -566.79. The company’s 50-day simple moving average is GBX 9.51 and its 200 day simple moving average is GBX 12.61. The stock has a market capitalization of £86.39 million, a price-to-earnings ratio of -12.79 and a beta of 0.35.

Scancell (LON:SCLP) last released its quarterly earnings results on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) earnings per share (EPS) for the quarter. Equities research analysts forecast that Scancell Holdings plc will post -2.5361112 EPS for the current year.

Scancell Company Profile

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.